The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
The dynamic control of signal transduction networks in cancer cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Network motifs: simple building blocks of complex networks.
Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., & Alon, U. (2002) · Science · doi:10.1126/science.298.5594.824 · Cited by 7,368
Cybernetics or Control and Communication in the Animal and the Machine
Wiener, N. (2019) · The MIT Press eBooks · doi:10.7551/mitpress/11810.001.0001 · Cited by 5,009
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
Cybernetics. Or Control and Communication in the Animal and the Machine
N., E., & Wiener, N. (1949) · The Journal of Philosophy · doi:10.2307/2020260 · Cited by 3,590
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
Cell-signalling dynamics in time and space
Kholodenko, B. N. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1838 · Cited by 1,347
Self-citationAn amplified sensitivity arising from covalent modification in biological systems.
Goldbeter, A., & Koshland, D. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6840 · Cited by 1,206
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.033 · Cited by 1,075
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Turke, A. B., Zejnullahu, K., Wu, Y.-L., Song, Y., Dias-Santagata, D., Lifshits, E., Toschi, L., Rogers, A., Mok, T., Sequist, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.022 · Cited by 1,059
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Molecular interpretation of ERK signal duration by immediate early gene products
Murphy, L. O., Smith, S., Chen, R.-H., Fingar, D. C., & Blenis, J. (2002) · Nature Cell Biology · doi:10.1038/ncb822 · Cited by 929
Defining Network Topologies that Can Achieve Biochemical Adaptation
Ma, W., Trusina, A., El-Samad, H., Lim, W. A., & Tang, C. (2009) · Cell · doi:10.1016/j.cell.2009.06.013 · Cited by 919
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Self-citationReversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature · doi:10.1038/nature13121 · Cited by 888
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 818
p53 Dynamics Control Cell Fate
Purvis, J. E., Karhohs, K. W., Mock, C., Batchelor, E., Loewer, A., & Lahav, G. (2012) · Science · doi:10.1126/science.1218351 · Cited by 770
In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Das Thakur, M., Salangsang, F., Landman, A. S., Sellers, W. R., Pryer, N. K., Levesque, M. P., Dummer, R., McMahon, M., & Stuart, D. D. (2013) · Nature · doi:10.1038/nature11814 · Cited by 730
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
Nieto, M. A. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154036 · Cited by 720
Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells
Irish, J. M., Hovland, R., Krutzik, P. O., Perez, O. D., Bruserud, Ø., Gjertsen, B. T., & Nolan, G. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.028 · Cited by 684
Lee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M., Sorger, P. K., MacBeath, G., & Yaffe, M. B. (2012) · Cell · doi:10.1016/j.cell.2012.03.031 · Cited by 680
Evolutionary dynamics of cancer in response to targeted combination therapy
Bozic, I., Reiter, J. G., Allen, B., Antal, T., Chatterjee, K., Shah, P., Moon, Y. S., Yaqubie, A., Kelly, N., Le, D. T., et al. (2013) · eLife · doi:10.7554/elife.00747 · Cited by 617
Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate
Santos, S. D. M., Verveer, P. J., & Bastiaens, P. I. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1543 · Cited by 609
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K. S., Testori, A., Larue, L., & Goding, C. R. (2006) · Genes & Development · doi:10.1101/gad.406406 · Cited by 608
Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
Zimmermann, G., Papke, B., Ismail, S., Vartak, N., Chandra, A., Hoffmann, M., Hahn, S. A., Triola, G., Wittinghofer, A., Bastiaens, P. I. H., et al. (2013) · Nature · doi:10.1038/nature12205 · Cited by 596
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Cohen, A. A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008) · Science · doi:10.1126/science.1160165 · Cited by 596
Molecular mechanisms underlying RB protein function
Dick, F. A., & Rubin, S. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3567 · Cited by 569
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
Walz, S., Lorenzin, F., Morton, J., Wiese, K. E., von Eyss, B., Herold, S., Rycak, L., Dumay-Odelot, H., Karim, S., Bartkuhn, M., et al. (2014) · Nature · doi:10.1038/nature13473 · Cited by 502
A negative feedback signaling network underlies oncogene-induced senescence
Courtois-Cox, S., Genther Williams, S. M., Reczek, E. E., Johnson, B. W., McGillicuddy, L. T., Johannessen, C. M., Hollstein, P. E., MacCollin, M., & Cichowski, K. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.003 · Cited by 501
Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases
Zarkowska, T., & Mittnacht, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12738 · Cited by 493
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Sabò, A., Kress, T. R., Pelizzola, M., de Pretis, S., Gorski, M. M., Tesi, A., Morelli, M. J., Bora, P., Doni, M., Verrecchia, A., et al. (2014) · Nature · doi:10.1038/nature13537 · Cited by 489
A module of negative feedback regulators defines growth factor signaling
Amit, I., Citri, A., Shay, T., Lu, Y., Katz, M., Zhang, F., Tarcic, G., Siwak, D., Lahad, J., Jacob-Hirsch, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1987 · Cited by 488
Frequency-Modulated Pulses of ERK Activity Transmit Quantitative Proliferation Signals
Albeck, J. G., Mills, G. B., & Brugge, J. S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.11.002 · Cited by 487
MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination
Lu, M., Jolly, M. K., Levine, H., Onuchic, J. N., & Ben-Jacob, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318192110 · Cited by 487
Posttranslational Modification of p53: Cooperative Integrators of Function
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 483
Zhang, J., Tian, X.-J., Zhang, H., Teng, Y., Li, R., Bai, F., Elankumaran, S., & Xing, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005304 · Cited by 462
Bentley, N. J., Eisen, T., & Goding, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7996 · Cited by 450
Dissecting cancer through mathematics: From the cell to the animal model
Byrne, H. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2808 · Cited by 442
Huang, R. Y.-J., Wong, M. K., Tan, T. Z., Kuay, K. T., Ng, A. H. C., Chung, V. Y., Chu, Y.-S., Matsumura, N., Lai, H.-C., Lee, Y. F., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.442 · Cited by 427
A bistable Rb–E2F switch underlies the restriction point
Yao, G., Lee, T. J., Mori, S., Nevins, J. R., & You, L. (2008) · Nature Cell Biology · doi:10.1038/ncb1711 · Cited by 425
Du, J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R., & Fisher, D. E. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.014 · Cited by 421
Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
Self-citationThe Restriction Point of the Cell Cycle
Blagosklonny, M. V., & Pardee, A. B. (2002) · Cell Cycle · doi:10.4161/cc.1.2.108 · Cited by 412
Virchow, V. R. (1861) · The American Journal of the Medical Sciences · doi:10.1097/00000441-186104000-00025 · Cited by 400
Defining Stem Cell Dynamics in Models of Intestinal Tumor Initiation
Vermeulen, L., Morrissey, E., van der Heijden, M., Nicholson, A. M., Sottoriva, A., Buczacki, S., Kemp, R., Tavaré, S., & Winton, D. J. (2013) · Science · doi:10.1126/science.1243148 · Cited by 397
Only three driver gene mutations are required for the development of lung and colorectal cancers
Tomasetti, C., Marchionni, L., Nowak, M. A., Parmigiani, G., & Vogelstein, B. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421839112 · Cited by 395
Yeung, K. C., Rose, D. W., Dhillon, A. S., Yaros, D., Gustafsson, M., Chatterjee, D., McFerran, B., Wyche, J., Kolch, W., & Sedivy, J. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7207-7217.2001 · Cited by 387
Self-citationFrom genes to drugs: targeted strategies for melanoma
Flaherty, K. T., Hodi, F. S., & Fisher, D. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3218 · Cited by 354
Realistic control of network dynamics
Cornelius, S. P., Kath, W. L., & Motter, A. E. (2013) · Nature Communications · doi:10.1038/ncomms2939 · Cited by 352
Tailoring to RB: tumour suppressor status and therapeutic response
Knudsen, E. S., & Knudsen, K. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2401 · Cited by 344
Stimulus‐dependent dynamics of p53 in single cells
Batchelor, E., Loewer, A., Mock, C., & Lahav, G. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.20 · Cited by 322
Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1
O'Neill, E., Rushworth, L., Baccarini, M., & Kolch, W. (2004) · Science · doi:10.1126/science.1103233 · Cited by 317
Self-citationSelective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Chen, Y.-N. P., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., Adams, P. D., Bair, K. W., & Kaelin, W. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4325 · Cited by 314
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Soucek, L., Whitfield, J. R., Sodir, N. M., Massó-Vallés, D., Serrano, E., Karnezis, A. N., Swigart, L. B., & Evan, G. I. (2013) · Genes & Development · doi:10.1101/gad.205542.112 · Cited by 301
Evidence that Fold-Change, and Not Absolute Level, of β-Catenin Dictates Wnt Signaling
Goentoro, L., & Kirschner, M. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.017 · Cited by 300
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., Bartel, F., Taubert, H., Wuerl, P., Hait, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0180 · Cited by 287
Cell fate decisions are specified by the dynamic ERK interactome
von Kriegsheim, A., Baiocchi, D., Birtwistle, M., Sumpton, D., Bienvenut, W., Morrice, N., Yamada, K., Lamond, A., Kalna, G., Orton, R., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1994 · Cited by 286
Self-citationMeyer, A. S., Miller, M. A., Gertler, F. B., & Lauffenburger, D. A. (2013) · Science Signaling · doi:10.1126/scisignal.2004155 · Cited by 284
Regulation of Raf-1 activation and signalling by dephosphorylation
Dhillon, A. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280
Almendro, V., Cheng, Y.-K., Randles, A., Itzkovitz, S., Marusyk, A., Ametller, E., Gonzalez-Farre, X., Muñoz, M., Russnes, H. G., Helland, Å., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.041 · Cited by 274
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., Le Gras, S., Cormont, M., Ballotti, R., Bertolotto, C., et al. (2011) · Oncogene · doi:10.1038/onc.2010.612 · Cited by 269
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Vredeveld, L. C. W., Possik, P. A., Smit, M. A., Meissl, K., Michaloglou, C., Horlings, H. M., Ajouaou, A., Kortman, P. C., Dankort, D., McMahon, M., et al. (2012) · Genes & Development · doi:10.1101/gad.187252.112 · Cited by 262
The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier
Sturm, O. E., Orton, R., Grindlay, J., Birtwistle, M., Vyshemirsky, V., Gilbert, D., Calder, M., Pitt, A., Kholodenko, B., & Kolch, W. (2010) · Science Signaling · doi:10.1126/scisignal.2001212 · Cited by 247
Self-citationLigand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics
Nakakuki, T., Birtwistle, M. R., Saeki, Y., Yumoto, N., Ide, K., Nagashima, T., Brusch, L., Ogunnaike, B. A., Okada-Hatakeyama, M., & Kholodenko, B. N. (2010) · Cell · doi:10.1016/j.cell.2010.03.054 · Cited by 241
Self-citationLigand‐dependent responses of the ErbB signaling network: experimental and modeling analyses
Birtwistle, M. R., Hatakeyama, M., Yumoto, N., Ogunnaike, B. A., Hoek, J. B., & Kholodenko, B. N. (2007) · Molecular Systems Biology · doi:10.1038/msb4100188 · Cited by 234
Self-citationCheli, Y., Guiliano, S., Botton, T., Rocchi, S., Hofman, V, Hofman, P., Bahadoran, P., Bertolotto, C., & Ballotti, R. (2011) · Oncogene · doi:10.1038/onc.2010.598 · Cited by 231
Protein kinases of the Hippo pathway: Regulation and substrates
Avruch, J., Zhou, D., Fitamant, J., Bardeesy, N., Mou, F., & Barrufet, L. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.07.002 · Cited by 228
Why cytoplasmic signalling proteins should be recruited to cell membranes
Kholodenko, B. N., Hoek, J. B., & Westerhoff, H. V. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01741-4 · Cited by 226
Self-citationSystems-level interactions between insulin–EGF networks amplify mitogenic signaling
Borisov, N., Aksamitiene, E., Kiyatkin, A., Legewie, S., Berkhout, J., Maiwald, T., Kaimachnikov, N. P., Timmer, J., Hoek, J. B., & Kholodenko, B. N. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.19 · Cited by 222
Self-citationQuantitative analysis of signaling networks
Sauro, H. M., & Kholodenko, B. N. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2004.03.002 · Cited by 217
Self-citationThe circadian timing system in clinical oncology
Innominato, P. F., Roche, V. P., Palesh, O. G., Ulusakarya, A., Spiegel, D., & Lévi, F. A. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.916990 · Cited by 213
The lymph node microenvironment and its role in the progression of metastatic cancer
Pereira, E. R., Jones, D., Jung, K., & Padera, T. P. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.01.008 · Cited by 204
Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
Chapman, A., Fernandez del Ama, L., Ferguson, J., Kamarashev, J., Wellbrock, C., & Hurlstone, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.045 · Cited by 203
Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma Development
Cheung, M., Sharma, A., Madhunapantula, S. V., & Robertson, G. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5867 · Cited by 196
Kiyatkin, A., Aksamitiene, E., Markevich, N. I., Borisov, N. M., Hoek, J. B., & Kholodenko, B. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600482200 · Cited by 195
Self-citationStrong negative feedback from Erk to Raf confers robustness to MAPK signalling
Fritsche‐Guenther, R., Witzel, F., Sieber, A., Herr, R., Schmidt, N., Braun, S., Brummer, T., Sers, C., & Blüthgen, N. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.27 · Cited by 192
Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells
Tyson, J. J., Baumann, W. T., Chen, C., Verdugo, A., Tavassoly, I., Wang, Y., Weiner, L. M., & Clarke, R. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3081 · Cited by 189
Function, regulation and pathological roles of the Gab/DOS docking proteins
Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-22 · Cited by 171
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Ha, L., Ichikawa, T., Anver, M. R., Dickins, R. A., Lowe, S. W., Sharpless, N. E., Krimpenfort, P., DePinho, R. A., Bennett, D. C., Sviderskaya, E. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611638104 · Cited by 168
Quantification of information transfer via cellular signal transduction pathways
(1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01018-1 · Cited by 166
Phosphorylation network dynamics in the control of cell cycle transitions
Fisher, D., Krasińska, L., Coudreuse, D. Y. M., & Novák, B. (2012) · Journal of Cell Science · doi:10.1242/jcs.106351 · Cited by 160
Faratian, D., Goltsov, A., Lebedeva, G., Sorokin, A., Moodie, S., Mullen, P., Kay, C., Um, I. H., Langdon, S., Goryanin, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0777 · Cited by 159
Network quantification of EGFR signaling unveils potential for targeted combination therapy
Klinger, B., Sieber, A., Fritsche‐Guenther, R., Witzel, F., Berry, L., Schumacher, D., Yan, Y., Durek, P., Merchant, M. A., Schäfer, R., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.29 · Cited by 158
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma
Seidel, C., Schagdarsurengin, U., Blümke, K., Würl, P., Pfeifer, G. P., Hauptmann, S., Taubert, H. W., & Dammann, R. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20317 · Cited by 157
Shin, S., Rath, O., Zebisch, A., Choo, S., Kölch, W., & Cho, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1377 · Cited by 157
Spatial organization of intracellular communication: insights from imaging
Dehmelt, L., & Bastiaens, P. I. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2903 · Cited by 151
Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
Romano, D., Nguyen, L. K., Matallanas, D., Halász, M., Doherty, C., Kholodenko, B. Ν., & Kölch, W. (2014) · Nature Cell Biology · doi:10.1038/ncb2986 · Cited by 151
Self-citationMutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
Matallanas, D., Romano, D., Al‐Mulla, F., O’Neill, E. E., Al-Ali, W., Crespo, P., Doyle, B. J., Nixon, C., Sansom, O. J., Drosten, M., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.016 · Cited by 149
Lee, J., Lee, J., Farquhar, K. S., Yun, J., Frankenberger, C. A., Bevilacqua, E., Yeung, K. C., Kim, E., Balázsi, G., & Rosner, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304840111 · Cited by 146
Taming of the beast: shaping Myc-dependent amplification
Wolf, E., Lin, C. Y., Eilers, M., & Levens, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.006 · Cited by 139
Origin of bistability underlying mammalian cell cycle entry
Yao, G., Tan, C., West, M., Nevins, J. R., & You, L. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.19 · Cited by 139
Mammalian Hippo pathway: from development to cancer and beyond
Bao, Y., Hata, Y., Ikeda, M., & Withanage, K. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr021 · Cited by 137
Shoval, O., & Alon, U. S. (2010) · Cell · doi:10.1016/j.cell.2010.09.050 · Cited by 135
Peter, S., Bultinck, J., Myant, K., Jaenicke, L. A., Walz, S., Müller, J., Gmachl, M., Treu, M., Boehmelt, G., Ade, C. P., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403927 · Cited by 131
Single cell analysis of cancer genomes
Loo, P. V., & Voet, T. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.004 · Cited by 129
Wu, K., & Bonavida, B. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i3.40 · Cited by 126
Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt
Romano, D., Matallanas, D., Weitsman, G. E., Preisinger, C., Ng, T., & Kölch, W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3147 · Cited by 117
Hu, W., Feng, Z., Ma, L., Wagner, J., Rice, J. J., Stolovitzky, G. A., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2656 · Cited by 114
Lister, J. A., Capper, A., Zeng, Z., Mathers, M. E., Richardson, J., Paranthaman, K., Jackson, I. J., & Patton, E. E. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.293 · Cited by 107
Feedback loops and reciprocal regulation: recurring motifs in the systems biology of the cell cycle
Ferrell, J. E. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.007 · Cited by 106
Intratumor heterogeneity alters most effective drugs in designed combinations
Zhao, B., Hemann, M. T., & Lauffenburger, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323934111 · Cited by 105
Single-cell gene expression signatures reveal melanoma cell heterogeneity
Ennen, M., Keime, C., Kobi, D., Mengus, G., Lipsker, D. M., Thibault-Carpentier, C., & Davidson, I. (2014) · Oncogene · doi:10.1038/onc.2014.262 · Cited by 100
Complexity of Receptor Tyrosine Kinase Signal ProcessingPreprint
Volinsky, N., & Kholodenko, B. Ν. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009043 · Cited by 99
Self-citationAddressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
Zhao, B., Pritchard, J. R., Lauffenburger, D. A., & Hemann, M. T. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0465 · Cited by 98
Raf kinase inhibitor protein (RKIP) in cancer
Escara-Wilke, J. F., Yeung, K. C., & Keller, E. T. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9365-9 · Cited by 94
Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis
To, M. D., Rosario, R. D., Westcott, P. M. K., Banta, K. L., & Balmain, A. (2012) · Oncogene · doi:10.1038/onc.2012.404 · Cited by 92
Aoki, K., Kamioka, Y., & Matsuda, M. (2013) · Development Growth & Differentiation · doi:10.1111/dgd.12039 · Cited by 90
Lee, Y.-M., & Siciński, P. (2006) · Cell Cycle · doi:10.4161/cc.5.18.3218 · Cited by 90
Activation of diverse signalling pathways by oncogenic PIK3CA mutations
Wu, X., Renuse, S., Sahasrabuddhe, N. A., Zahari, M. S., Chaerkady, R., Kim, M., Nirujogi, R. S., Mohseni, M., Kumar, P., Raju, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5961 · Cited by 90
The butterfly effect in cancer: A single base mutation can remodel the cell
Hart, J. R., Zhang, Y., Liao, L., Ueno, L. A., Du, L., Jonkers, M., Yates, J. R., & Vogt, P. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424012112 · Cited by 89
Sharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Yu, H., McDaid, R., Lee, J., Possik, P. A., Li, L., Kumar, S. M., Elder, D. E., Belle, P. A. V., Gimotty, P. A., Guerra, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081057 · Cited by 85
Iglesias, D. A., Yates, M. S., van der Hoeven, D., Rodkey, T. L., Zhang, Q., Co, N. N., Burzawa, J. K., Chigurupati, S., Celestino, J., Bowser, J. L., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0439 · Cited by 82
A Circadian Clock Transcription Model for the Personalization of Cancer Chronotherapy
Li, X., Ali Mohammad-djafari, A., Dumitru, M., Dulong, S., Filipski, E., Siffroi‐Fernandez, S., Mteyrek, A., Scaglione, F., Guettier, C., Delaunay, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1528 · Cited by 78
CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
Bonelli, P., Tuccillo, F. M., Borrelli, A., Schiattarella, A., & Buonaguro, F. M. (2014) · BioMed Research International · doi:10.1155/2014/361020 · Cited by 75
Yesilkanal, A. E., & Rosner, M. R. (2014) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2014012000 · Cited by 70
Raf Inhibitors Target Ras Spatiotemporal Dynamics
Cho, K.-J., Kasai, R. S., Park, J.-H., Chigurupati, S., Heidorn, S. J., van der Hoeven, D., Plowman, S. J., Kusumi, A., Marais, R., & Hancock, J. F. (2012) · Current Biology · doi:10.1016/j.cub.2012.03.067 · Cited by 68
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale
Barber, L. J., Davies, M. N., & Gerlinger, M. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.12.001 · Cited by 62
Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex
Conradie, R., Bruggeman, F. J., Ciliberto, A., Csikász‐Nagy, A., Novák, B., Westerhoff, H. V., & Snoep, J. L. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07473.x · Cited by 61
Blüthgen, N., Legewie, S., Kiełbasa, S. M., Schramme, A., Tchernitsa, O. I., Keil, J., Solf, A., Vingron, M., Schäfer, R., Herzel, H., et al. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06846.x · Cited by 58
Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer
Grothey, A. A., & Lenz, H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.4194 · Cited by 53
MITF, the Janus Transcription Factor of Melanoma
Koludrović, D., & Davidson, I. (2013) · Future Oncology · doi:10.2217/fon.12.177 · Cited by 49
Sample, V., Mehta, S., & Zhang, J. (2014) · Journal of Cell Science · doi:10.1242/jcs.099994 · Cited by 48
Role of the host stroma in cancer and its therapeutic significance
Jackson, D. G. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9438-4 · Cited by 43
Analysis of growth factor signaling in genetically diverse breast cancer lines
Niepel, M., Hafner, M. A., Pace, E. A., Chung, M., Chai, D. H., Zhou, L., Muhlich, J. L., Schoeberl, B., & Sorger, P. K. (2014) · BMC Biology · doi:10.1186/1741-7007-12-20 · Cited by 43
A Hippo in the ointment: MST signalling beyond the fly
Matallanas, D., Romano, D., Hamilton, G., Kölch, W., & O’Neill, E. E. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5630 · Cited by 41
Functional characterization of cancer-associated Gab1 mutations
Ortiz-Padilla, C., Gallego‐Ortega, D., Browne, B. C., Hochgräfe, F., Caldon, C. E., Lyons, R. J., Croucher, D. R., Rickwood, D., Ormandy, C. J., Brummer, T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.271 · Cited by 37
Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling device
Nguyen, L. K., Matallanas, D., Romano, D., Kholodenko, B. Ν., & Kölch, W. (2015) · Cell Cycle · doi:10.4161/15384101.2014.973743 · Cited by 29
Self-citationDobrzyński, M., Nguyen, L. K., Birtwistle, M. R., von Kriegsheim, A., Blanco, A., Cheong, A., Kölch, W., & Kholodenko, B. Ν. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0383 · Cited by 28
Self-citationThe APC Network Regulates the Removal of Mutated Cells from Colonic Crypts
Song, J.-H., Huels, D. J., Ridgway, R. A., Sansom, O. J., Kholodenko, B. Ν., Kölch, W., & Cho, K. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.043 · Cited by 24
Self-citation
Cited by
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Lee, S., Rauch, J., & Kolch, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031102 · Cited by 799
Self-citationAn, Z., Aksoy, O., Zheng, T., Fan, Q.-W., & Weiss, W. A. (2018) · Oncogene · doi:10.1038/s41388-017-0045-7 · Cited by 668
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Icard, P., Shulman, S., Farhat, D., Steyaert, J.-M., Alifano, M., & Lincet, H. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.001 · Cited by 643
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502
Molecular mechanisms for tumour resistance to chemotherapy
Pan, S., Li, Z., He, Z., Qiu, J., & Zhou, S. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12581 · Cited by 401
Metadata
- Authors
- Kolch, W., Halasz, M., Granovskaya, M., & Kholodenko, B. N.
- Venue
- Nature Reviews Cancer
- Published
- 2015-08-20
- Volume
- 15
- Issue
- 9
- Pages
- 515-527
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1826266252
- Cited by
- 339
- References
- 146
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.